Market Closed -
Singapore S.E.
01:08:01 02/11/2021 pm IST
|
5-day change
|
1st Jan Change
|
0.075
SGD
|
-6.25%
|
|
-.--%
|
-.--%
|
Fiscal Period: June |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
49.38
|
36.77
|
38.54
|
28.42
|
18.6
|
11.59
|
Enterprise Value (EV)
1 |
28.18
|
22.46
|
47.29
|
37.57
|
26.75
|
17.29
|
P/E ratio
|
-26
x
|
-11.1
x
|
-49.5
x
|
-3.16
x
|
-0.97
x
|
-0.33
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.11
x
|
0.05
x
|
0.06
x
|
0.08
x
|
0.44
x
|
0.39
x
|
EV / Revenue
|
0.07
x
|
0.03
x
|
0.08
x
|
0.1
x
|
0.64
x
|
0.59
x
|
EV / EBITDA
|
-20.2
x
|
-46.3
x
|
13.8
x
|
7.76
x
|
9.05
x
|
-68.1
x
|
EV / FCF
|
0.95
x
|
144
x
|
-5.82
x
|
3.32
x
|
-9.39
x
|
0.63
x
|
FCF Yield
|
106%
|
0.7%
|
-17.2%
|
30.1%
|
-10.6%
|
159%
|
Price to Book
|
1.33
x
|
0.88
x
|
0.88
x
|
0.89
x
|
1.31
x
|
-0.54
x
|
Nbr of stocks (in thousands)
|
1,37,244
|
1,64,198
|
2,08,465
|
2,08,465
|
2,08,465
|
2,08,465
|
Reference price
2 |
0.3598
|
0.2239
|
0.1849
|
0.1363
|
0.0892
|
0.0556
|
Announcement Date
|
15/10/17
|
15/10/18
|
16/10/19
|
14/10/20
|
14/10/21
|
04/09/23
|
Fiscal Period: June |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
433
|
692.5
|
605.5
|
375
|
42.04
|
29.41
|
EBITDA
1 |
-1.396
|
-0.4852
|
3.427
|
4.839
|
2.957
|
-0.254
|
EBIT
1 |
-1.472
|
-0.6905
|
2.536
|
3.419
|
1.246
|
-1.729
|
Operating Margin
|
-0.34%
|
-0.1%
|
0.42%
|
0.91%
|
2.96%
|
-5.88%
|
Earnings before Tax (EBT)
1 |
-1.843
|
-2.971
|
0.3569
|
-7.773
|
0.457
|
-34.82
|
Net income
1 |
-1.794
|
-3.124
|
-0.6846
|
-8.999
|
-19.19
|
-35.31
|
Net margin
|
-0.41%
|
-0.45%
|
-0.11%
|
-2.4%
|
-45.64%
|
-120.06%
|
EPS
2 |
-0.0138
|
-0.0201
|
-0.003732
|
-0.0432
|
-0.0920
|
-0.1694
|
Free Cash Flow
1 |
29.76
|
0.1562
|
-8.126
|
11.31
|
-2.848
|
27.5
|
FCF margin
|
6.87%
|
0.02%
|
-1.34%
|
3.02%
|
-6.77%
|
93.51%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
233.83%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
15/10/17
|
15/10/18
|
16/10/19
|
14/10/20
|
14/10/21
|
04/09/23
|
Fiscal Period: June |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
8.75
|
9.15
|
8.15
|
5.69
|
Net Cash position
1 |
21.2
|
14.3
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
2.553
x
|
1.891
x
|
2.756
x
|
-22.41
x
|
Free Cash Flow
1 |
29.8
|
0.16
|
-8.13
|
11.3
|
-2.85
|
27.5
|
ROE (net income / shareholders' equity)
|
-5.39%
|
-7.23%
|
0.24%
|
-20.9%
|
0.24%
|
1,199%
|
ROA (Net income/ Total Assets)
|
-1.38%
|
-0.45%
|
1.39%
|
1.97%
|
1.13%
|
-2.87%
|
Assets
1 |
130
|
699.1
|
-49.26
|
-456.9
|
-1,704
|
1,232
|
Book Value Per Share
2 |
0.2700
|
0.2500
|
0.2100
|
0.1500
|
0.0700
|
-0.1000
|
Cash Flow per Share
2 |
0.2100
|
0.2000
|
0.0900
|
0.0900
|
0.0300
|
0.0100
|
Capex
1 |
0.01
|
0.31
|
0.22
|
0.15
|
2.35
|
0.18
|
Capex / Sales
|
0%
|
0.04%
|
0.04%
|
0.04%
|
5.58%
|
0.59%
|
Announcement Date
|
15/10/17
|
15/10/18
|
16/10/19
|
14/10/20
|
14/10/21
|
04/09/23
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 11.62M | | +19.58% | 85.64B | | -27.13% | 70.63B | | +4.65% | 27.05B | | -5.71% | 17.97B | | +1.60% | 17.58B | | +3.44% | 15.64B | | +7.79% | 13.55B | | +9.91% | 13.41B | | +73.16% | 13.18B |
Other Healthcare Facilities & Services
|